Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimolegin vs Clexane for VTE prevention in joint replacement surgery
NCT07124819Phase 3Completed
- Sponsor
- Avexima
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimolegin in venous thromboembolism (VTE), sponsored by Avexima. Started Jul 2024; status: completed.
02
Drugs
dimolegin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07124819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124819.